<DOC>
	<DOCNO>NCT00024466</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop cancer cell divide stop grow die . Vaccines make person 's cancer cell may make body build immune response kill cancer cell . Peripheral stem cell transplantation may able replace immune cell destroy chemotherapy . Combining chemotherapy vaccine therapy peripheral stem cell transplantation may effective treat multiple myeloma . PURPOSE : Phase I/II trial study effectiveness chemotherapy follow vaccine therapy peripheral stem cell transplantation treat patient newly diagnose multiple myeloma .</brief_summary>
	<brief_title>Chemotherapy , Vaccine Therapy , Peripheral Stem Cell Transplantation Treating Patients With Newly Diagnosed Multiple Myeloma</brief_title>
	<detailed_description>OBJECTIVES : - Determine efficacy induction chemotherapy follow autologous tumor cell vaccine autologous peripheral blood stem cell transplantation patient multiple myeloma . - Determine safety regimen patient . OUTLINE : Autologous tumor cell harvest . The vaccine prepare vitro mix autologous tumor cell bystander cell express sargramostim ( GM-CSF ) . Patients receive induction chemotherapy follow autologous tumor cell vaccination ( ATCV ) . Patients undergo autologous peripheral blood stem cell transplantation . At 6 week transplantation , patient receive additional ATCVs every 3 week total 8 vaccination . PROJECTED ACCRUAL : A total 25 patient accrue study .</detailed_description>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>Plasmacytoma</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Newly diagnose multiple myeloma More 30 % bone marrow involvement Eligible autologous peripheral blood stem cell transplantation PATIENT CHARACTERISTICS : Age : 18 70 Performance status : ECOG 02 Life expectancy : Not specify Hematopoietic : Absolute neutrophil count great 500/mm^3 Platelet count great 30,000/mm^3 Hepatic : Bilirubin le 3 time normal AST/ALT le 3 time normal Renal : Not specify Other : Not pregnant HIV negative No prior active autoimmune disease No prior malignancy within past 5 year No major active medical psychosocial problem PRIOR CONCURRENT THERAPY : Biologic therapy : See Disease Characteristics Chemotherapy : No 1 prior course chemotherapy Endocrine therapy : Not specify Radiotherapy : Concurrent local radiotherapy allow Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>stage I multiple myeloma</keyword>
	<keyword>stage II multiple myeloma</keyword>
	<keyword>stage III multiple myeloma</keyword>
</DOC>